- Home
- NAUT vs LUCD Comparison
NAUT vs LUCD Comparison
Compare NAUT & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- LUCD
- Stock Information
- Founded
- NAUT 2016
- LUCD 2018
- Country
- NAUT United States
- LUCD United States
- Employees
- NAUT N/A
- LUCD N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NAUT Industrials
- LUCD Health Care
- Exchange
- NAUT Nasdaq
- LUCD Nasdaq
- Market Cap
- NAUT 104.7M
- LUCD 108.0M
- IPO Year
- NAUT N/A
- LUCD 2021
- Fundamental
- Price
- NAUT $0.90
- LUCD $1.06
- Analyst Decision
- NAUT Strong Sell
- LUCD Strong Buy
- Analyst Count
- NAUT 1
- LUCD 5
- Target Price
- NAUT $1.75
- LUCD $3.70
- AVG Volume (30 Days)
- NAUT 394.7K
- LUCD 1.5M
- Earning Date
- NAUT 10-28-2025
- LUCD 11-12-2025
- Dividend Yield
- NAUT N/A
- LUCD N/A
- EPS Growth
- NAUT N/A
- LUCD N/A
- EPS
- NAUT N/A
- LUCD N/A
- Revenue
- NAUT N/A
- LUCD $4,360,000.00
- Revenue This Year
- NAUT N/A
- LUCD $13.90
- Revenue Next Year
- NAUT N/A
- LUCD $163.88
- P/E Ratio
- NAUT N/A
- LUCD N/A
- Revenue Growth
- NAUT N/A
- LUCD 14.74
- 52 Week Low
- NAUT $0.62
- LUCD $0.75
- 52 Week High
- NAUT $3.03
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- NAUT 60.66
- LUCD 46.24
- Support Level
- NAUT $0.69
- LUCD $1.00
- Resistance Level
- NAUT $0.92
- LUCD $1.07
- Average True Range (ATR)
- NAUT 0.06
- LUCD 0.03
- MACD
- NAUT 0.01
- LUCD -0.00
- Stochastic Oscillator
- NAUT 70.67
- LUCD 46.67
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.